Abstract
Methotrexate may rarely provoke serositis, even with low doses and after just a few weeks of therapy. We report here a rare case of pleuropericarditis due to methotrexate. The effusion resolved after the withdrawal of the drug and the beginning of anti-inflammatory therapy; there was no relapse during a 10-month follow-up.
MeSH terms
-
Anti-Inflammatory Agents / therapeutic use
-
Aspirin / therapeutic use
-
Chronic Disease
-
Colchicine / therapeutic use
-
Dermatologic Agents / adverse effects*
-
Dermatologic Agents / therapeutic use
-
Drug Therapy, Combination
-
Humans
-
Male
-
Methotrexate / adverse effects*
-
Methotrexate / therapeutic use
-
Middle Aged
-
Pericarditis / chemically induced*
-
Pericarditis / drug therapy
-
Pericarditis / microbiology
-
Pleurisy / chemically induced*
-
Pleurisy / drug therapy
-
Pleurisy / microbiology
-
Psoriasis / drug therapy*
-
Psoriasis / pathology
Substances
-
Anti-Inflammatory Agents
-
Dermatologic Agents
-
Aspirin
-
Colchicine
-
Methotrexate